HY004

BIOLOGICAL2 trials

Sponsors

Juventas Cell Therapy Ltd.

Conditions

B-cell Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma

Phase 1

Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

WithdrawnNCT06005649

Juventas Cell Therapy Ltd.Non-hodgkin Lymphoma

Start: 2025-09-30End: 2027-06-30Updated: 2025-08-08

A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL)

WithdrawnNCT06009107

Juventas Cell Therapy Ltd.B-cell Acute Lymphoblastic Leukemia

Start: 2025-06-30End: 2027-12-30Updated: 2025-08-08